QR Kod

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

Abstract Background/Objectives Immune checkpoint inhibitors are frequently used to treat advanced non-small cell lung cancer (NSCLC). Drug clearance also varies depending on patient-related factors. Therefore, the lung immune prognostic index (LIPI), based on inflammatory markers, may help predict p...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz, Mevlude Inanc, Metin Ozkan, Emel Mutlu Ozkan, Deniz Can Guven, Mustafa Erman, Latif Karahan, Elif Sahin, Anıl Karakayali, Pervin Can Sanci, Umut Kefeli, Devrim Cabuk, Erdem Kolemen, Mehmet Mutlu Kidi, Sedat Biter, Tolga Koseci, Muslih Urun, Berrak Mermit Ercek, Duygu Bayir, Gözde Agdas, Teoman Sakalar, Nargiz Majidova, Sedat Yildiz, Hacer Demir, Cengiz Akosman, Mustafa Ersoy, Saadettin Kilickap, Erkam Kocaaslan, Ezgi Turkoğlu, Sedat Yildirim, Hayati Arvas, Havva Yesil Cinkir, Aslihan Ezgi Apaydin Rollas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer 2026-02-01
Seri Bilgileri:Discover Oncology
Konular:
Non-small cell lung cancer
Lung immune prognostic index
Nivolumab
Survival
Lung immune prognostic index changes
Online Erişim:https://doi.org/10.1007/s12672-026-04705-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller